FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

679601000168106: B-Dose IV (dexpanthenol 20 mg / 2 mL + nicotinamide 100 mg / 2 mL + pyridoxine hydrochloride 50 mg / 2 mL + riboflavin sodium phosphate 5 mg / 2 mL + thiamine hydrochloride 10 mg / 2 mL) injection, 6 x 2 mL vials (containered trade product pack)


Status: current, Defined. Date: 31-Dec 2014. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3028851000168119 B-Dose IV (dexpanthenol 20 mg / 2 mL + nicotinamide 100 mg / 2 mL + pyridoxine hydrochloride 50 mg / 2 mL + riboflavin sodium phosphate 5 mg / 2 mL + thiamine hydrochloride 10 mg / 2 mL) injection, 6 x 2 mL vials (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3028861000168117 B-Dose IV injection, 6 x 2 mL vials en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
B-Dose IV injection, 6 x 2 mL vials has TPUU B-Dose IV injection, 2 mL vial true Inferred relationship Some 1
B-Dose IV injection, 6 x 2 mL vials Is a containered trade product pack true Inferred relationship Some
B-Dose IV injection, 6 x 2 mL vials Is a B-Dose IV injection, 6 x 2 mL vials true Inferred relationship Some
B-Dose IV injection, 6 x 2 mL vials has container type vial true Inferred relationship Some
B-Dose IV injection, 6 x 2 mL vials has TP B-Dose IV true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start